Health - Latest News Search Engine - Global and Local Breaking News

Health

Avidity Biosciences Announces the Accelerated Approval Regulatory Pathway in the U.S. is Open for Del-Brax and Initiates the Global, Confirmatory Phas...

-- Planning accelerated approval BLA submission in H2 2026, following topline data from FORTITUDE™ biomarker cohort in Q2 2026 -- -- Initiated global,...

Avidity Biosciences Announces the Accelerated Approval Regulatory Pathway in the U.S. is Open for Del-Brax and Initiates the Global, Confirmatory Phase 3 FORWARD™ Study in FSHD

Veritas Veterinary Partners Advances Strategic Growth Plan with Key Investments and Executive Appointments

TINTON FALLS, N.J., June 9, 2025 /PRNewswire/ -- Veritas Veterinary Partners ("Veritas" or the "Company"), a leading network of specialty and emergenc...

Veritas Veterinary Partners Advances Strategic Growth Plan with Key Investments and Executive Appointments

Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals

TAIPEI, June 9, 2025 /PRNewswire/ -- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, and Taiwan-based Formosa Pharmace...

Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals

WuXi Biologics Kicks off Construction of Microbial Manufacturing Site for Commercial Production in Chengdu

The microbial manufacturing site in Chengdu will be equipped with a 15,000L fermenter, enabling the production of 80 to 110 drug substance (DS) batche...

WuXi Biologics Kicks off Construction of Microbial Manufacturing Site for Commercial Production in Chengdu

Společnost Microtech oznamuje první implantace mikrosenzorů do srdečních síní v USA v rámci své studie FIH (jako první u člověka)

TEL AVIV, Izrael, 9. června 2025 /PRNewswire/ -- Společnost Microtech, stoprocentně vlastněná firmou Medinol, s potěšením oznamuje první implantace sv...

Společnost Microtech oznamuje první implantace mikrosenzorů do srdečních síní v USA v rámci své studie FIH (jako první u člověka)

H.I.G. Capital rondt overname van ITH Group Limited af

LONDEN, 9 juni 2025 /PRNewswire/ -- H.I.G. Capital ("H.I.G."), een toonaangevende wereldwijde alternatieve beleggingsonderneming met $ 70 miljard aan ...

H.I.G. Capital rondt overname van ITH Group Limited af

Microtech ogłasza pierwsze zabiegi wszczepienia mikroczujników do przedsionka serca w ramach badania FIH w USA

TEL AWIW, Izrael, 9 czerwca 2025 r. /PRNewswire/ - Microtech, podmiot zależny należący w całości do spółki Medinol, z radością ogłasza pierwsze wszcze...

Microtech ogłasza pierwsze zabiegi wszczepienia mikroczujników do przedsionka serca w ramach badania FIH w USA

Microtech oznamuje prvé implantácie predsieňových mikrosenzorov v USA v rámci štúdie FIH

TEL AVIV, Izrael, 9. jún 2025 /PRNewswire/ – Spoločnosť Microtech, stopercentná dcérska spoločnosť Medinol, s radosťou oznamuje prvé implantácie svojh...

Microtech oznamuje prvé implantácie predsieňových mikrosenzorov v USA v rámci štúdie FIH

Microtech объявляет о первой в США имплантации микродатчика предсердий в рамках проводимого компанией FIH-исследования

ТЕЛЬ-АВИВ, Израиль, 9 июня 2025 г. /PRNewswire/ -- Microtech, находящаяся в полной собственности дочерняя компания Medinol, рада объявить о первой в С...

Microtech объявляет о первой в США имплантации микродатчика предсердий в рамках проводимого компанией FIH-исследования

H.I.G. Capital Completes Acquisition of ITH Group Limited

LONDON, June 9, 2025 /PRNewswire/ -- H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $70 billion of capital under managem...

H.I.G. Capital Completes Acquisition of ITH Group Limited

TORL BioTherapeutics Announces Appointment of Anna Berkenblit, MD, MMSc, as Board Member

LOS ANGELES, June 9, 2025 /PRNewswire/ -- TORL BioTherapeutics LLC (TORL), a clinical-stage biotechnology company discovering and developing new antib...

TORL BioTherapeutics Announces Appointment of Anna Berkenblit, MD, MMSc, as Board Member

Microtech anuncia los primeros implantantes de microsensores auriculares en EE UU.

-Microtech anuncia los primeros implantantes de microsensores auriculares en EE UU. como parte de su estudio FIH TEL AVIV, Israel, 9 de junio de 2025 ...

Microtech anuncia los primeros implantantes de microsensores auriculares en EE UU.

Microtech annonce les premières implantations de microcapteurs auriculaires aux États-Unis dans le cadre de son étude FIH

TEL AVIV, Israël, 9 juin 2025 /PRNewswire/ -- Microtech, filiale à 100 % de Medinol, est heureuse d'annoncer les premières implantations aux États-Uni...

Microtech annonce les premières implantations de microcapteurs auriculaires aux États-Unis dans le cadre de son étude FIH

NHS calls for 200,000 new blood donors as supplies run low

The health service issued an "amber alert" last year and stocks remain low ever since.

NHS calls for 200,000 new blood donors as supplies run low

Nurses to vote on pay deal as potential strike looms

The ballot is being billed by representatives as the biggest single vote by the profession in the UK.

Nurses to vote on pay deal as potential strike looms

耶穌基督後期聖徒教會加強全球努力，將最初的捐贈預算翻倍，幫助改善全球超過 2,100 萬名婦女和兒童的生活

鹽湖城2025年6月9日 /美通社/ -- 耶穌基督後期聖徒教會 (The Church of Jesus Christ of Latter-day Saints) 一直肩負著照顧有需要的人的責任，為了改善婦女與兒童的福祉，教會正在加強其全球倡議。 2025 年 6 月 5 日（星期四）在猶他州鹽湖...

耶穌基督後期聖徒教會加強全球努力，將最初的捐贈預算翻倍，幫助改善全球超過 2,100 萬名婦女和兒童的生活

Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025

LUND, Sweden, June 9, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual investor e...

Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025

Everest Medicines Presents Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of Novel BTK Inhibitor EVER001 at the 62nd Congress ...

EVER001 is a covalent reversible BTK inhibitor with potentially best-in-class characteristics for the treatment of primary membranous nephropathy (pMN...

Everest Medicines Presents Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of Novel BTK Inhibitor EVER001 at the 62nd Congress of the European Renal Association

28bio Announces Nexon™ Neurotechnology Platform Powered by Engineered Human Brains

Exhibits complex neurological processes—including memory, learning, and cognition—and predicts human outcomes in preclinical drug development NEW ORLE...

28bio Announces Nexon™ Neurotechnology Platform Powered by Engineered Human Brains

Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA)...

HONG KONG, June 8, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of it...

Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA)